Ashiya, Japan

Okumoto Itsuo

This inventor holds 1 USPTO granted patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Okumoto Itsuo. Retrieved from https://idiyas.com/inventor/okumoto-itsuo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 1980

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Okumoto Itsuo: Innovator in Guanidinobenzoic Acid Compounds

Introduction

Okumoto Itsuo is a notable inventor based in Ashiya, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on Guanidinobenzoic acid compounds.

Latest Patents

Okumoto holds a patent for Guanidinobenzoic acid compounds and the process for preparing the same. This patent describes Guanidinobenzoic acid compounds represented by a specific formula, wherein R and Z are defined within the patent. These compounds exhibit anti-plasmin and anti-trypsin activities, and the patent also details a pharmaceutical composition and a method for inhibiting the activity of plasmin and trypsin.

Career Highlights

Okumoto is associated with Ono Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in pharmaceutical applications. His work has led to the creation of valuable compounds that have potential therapeutic uses.

Collaborations

Throughout his career, Okumoto has collaborated with esteemed colleagues, including Setsuro Fujii and Tsuyoshi Watanabe. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Okumoto Itsuo's contributions to the field of pharmaceutical chemistry, particularly through his patent on Guanidinobenzoic acid compounds, highlight his role as a significant inventor. His work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…